Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

2.

St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.

Laakmann G, Schüle C, Baghai T, Kieser M.

Pharmacopsychiatry. 1998 Jun;31 Suppl 1:54-9.

PMID:
9684948
3.
4.

Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.

Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.

Eur Neuropsychopharmacol. 2008 Nov;18(11):803-13. doi: 10.1016/j.euroneuro.2008.06.006. Epub 2008 Aug 9.

PMID:
18694635
6.

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.

Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.

J Clin Psychopharmacol. 2005 Oct;25(5):441-7.

PMID:
16160619
7.

Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials.

Kasper S, Gastpar M, Müller WE, Volz HP, Dienel A, Kieser M, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2008 Feb;258(1):59-63. Epub 2007 Dec 14. Review.

PMID:
18084790
8.
9.
10.
11.

Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.

Lecrubier Y, Clerc G, Didi R, Kieser M.

Am J Psychiatry. 2002 Aug;159(8):1361-6.

PMID:
12153829
12.

Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.

Szegedi A, Kohnen R, Dienel A, Kieser M.

BMJ. 2005 Mar 5;330(7490):503. Epub 2005 Feb 11. Erratum in: BMJ. 2005 Apr 2;330(7494):759. Dosage error in article text.

13.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
15.

Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression.

Behnke K, Jensen GS, Graubaum HJ, Gruenwald J.

Adv Ther. 2002 Jan-Feb;19(1):43-52.

PMID:
12008860
16.

Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities.

Laakmann G, Dienel A, Kieser M.

Phytomedicine. 1998 Dec;5(6):435-42. doi: 10.1016/S0944-7113(98)80039-1.

PMID:
23196026
17.

Placebo controlled continuation treatment with Hypericum extract WS 5570 after recovery from a mild or moderate depressive episode.

Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M.

Wien Med Wochenschr. 2007;157(13-14):362-6.

PMID:
17704988
19.

Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort.

Friede M, Henneicke von Zepelin HH, Freudenstein J.

Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S38-41.

PMID:
11518073
20.

The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.

Randløv C, Mehlsen J, Thomsen CF, Hedman C, von Fircks H, Winther K.

Phytomedicine. 2006 Mar;13(4):215-21. Epub 2006 Jan 19.

PMID:
16423519
Items per page

Supplemental Content

Write to the Help Desk